3rd Annual Biosimilars and Biobetters Congress, 20-21 Apr, 2015, London, UK

20-21 April, 2015

Novotel London West London, London, UK

 

3^RD Annual Biosimilars and Biobetters Congress

 

Oxford Global is proud to announce the 3^rd Annual Biosimilars & Biobetters Congress, taking place on 20^th – 21^st April 2015 in London, UK. The conference provides an exclusive opportunity for over 350 biologics experts working in biosimilars, proteins, antibodies and peptides to exchange their experiences and engage in scientific discussions.

 

Our highly esteemed speakers will explore the following key topic areas of the biosimilars industry:

 

Day 1 - Market Access Strategies, Opportunities And Commercial Challenges

       

      ►   Assessing the landscape of biosimilars: interchangeability and substitution

      ►   Evaluating the current market for biosimilar success: challenges, opportunities and barriers

      ►   Case studies on global commercialisation strategies

      ►   Market access initiatives and opportunities in emerging markets

      ►   Multiple perspectives: clinicians, industry leaders an payers

      ►   Regulatory updates on biosimilars

      ►   Balancing technological innovation with regulatory requirements

 

Day 2 – Developing Biosimilars & Biobetters

 

      ►   Demonstrating biosimilarity: challenges and solutions

      ►   Clinical and non-clinical advances in biosimilars

      ►   Characterisation methods: physio-chemical and structural characterisation, glycosylation analysis

      ►   Future challenges and obstacles in biosimilar development

      ►   Ensuring the quality of follow-on biologics: analytical testing, downstream processing

      ►   Analytical development and formulation strategies for follow-on biologics

Key speakers include:

      ►   Rakesh Dixit, Vice President R&D, Global Head, Biologics Safety Assessment, MedImmune delivering a presentation on the challenges and opportunities in developing best in class biosuperiors or biobetter biologics

      ►   Mehrshid Alai-Safar, Senior Director Regulatory Affairs, Baxter speaking on the comparison of FDA and EMA regulatory guidelines

      ►   Hootan Khatami, Senior Medical Director, Global Medical Affairs, Sanofi providing an overview of the insulin biosimilars

 

The congress forms part of Oxford Global’s highly successful Biologics Series. The event is co-located with our highly successful 8^th Annual Proteins & Antibodies Congress and the highly anticipated 2^nd Annual Peptides Congress.

 

To view the agenda and full list of speakers and presentations, please visit http://www.biosimilars-congress.com/download-agenda-marketing/

 

For further information and to enquire about available discounts, please contact Danielle Dalby on d.dalby@oxfordglobal.co.uk  or call +44 (0)1865 248455.